Insight Molecular Diagnostics Inc. (IMDX)

Insight Molecular Diagnostics Inc., formerly known as OncoCyte Corporation, is a molecular diagnostics company based in Irvine, California. It develops tests that help clinicians make treatment decisions using analysis of genetic material in blood and tissue.

The company's main focus is transplant medicine. Its donor-derived cell-free DNA technology measures DNA released by a transplanted organ into the recipient's bloodstream, providing a signal that can indicate organ injury or rejection. It offers this testing in kit form so that hospital and transplant center laboratories can run the assays locally rather than sending samples to a central lab.

Insight Molecular Diagnostics also has oncology-related assets from its earlier history and pursues partnerships to broaden the use of its testing platforms.